Variant report
Variant | nsv558753 |
---|---|
Chromosome Location | chr12:45363545-45400614 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:45366332..45368097-chr12:45514780..45516888,12 | MCF-7 | breast: | |
2 | chr12:45367140..45370350-chr12:45371616..45375145,3 | K562 | blood: | |
3 | chr12:45364370..45366746-chr12:45513644..45516185,2 | MCF-7 | breast: | |
4 | chr12:45366306..45367231-chr12:45516422..45517207,2 | MCF-7 | breast: | |
5 | chr12:45356113..45357820-chr12:45366859..45369459,2 | K562 | blood: | |
6 | chr12:45367140..45370350-chr12:45371616..45375145,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs268044 | chr12:45363545-45363546 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs140643601 | chr12:45363581-45363582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557208511 | chr12:45363620-45363621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575309817 | chr12:45363723-45363724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186980328 | chr12:45363768-45363769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs55786085 | chr12:45363771-45363772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532179125 | chr12:45363774-45363775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554333026 | chr12:45363779-45363780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547351439 | chr12:45363780-45363781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369101776 | chr12:45363788-45363789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572662875 | chr12:45363804-45363805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540161714 | chr12:45363848-45363849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565162178 | chr12:45363864-45363865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532030105 | chr12:45363886-45363887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544181014 | chr12:45363907-45363908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191451183 | chr12:45363968-45363969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529811592 | chr12:45363999-45364000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377050132 | chr12:45364012-45364013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150487665 | chr12:45364023-45364024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567861897 | chr12:45364042-45364043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78884038 | chr12:45364095-45364096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73288975 | chr12:45364114-45364115 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs548411551 | chr12:45364140-45364141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527729357 | chr12:45364154-45364155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538682757 | chr12:45364182-45364183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11182770 | chr12:45364184-45364185 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs149952265 | chr12:45366810-45366811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371864662 | chr12:45366811-45366812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116942186 | chr12:45366828-45366829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11182771 | chr12:45366870-45366871 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs116486758 | chr12:45366886-45366887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs537765218 | chr12:45366892-45366893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139191435 | chr12:45366898-45366899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565689434 | chr12:45366912-45366913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373609988 | chr12:45367058-45367059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549993235 | chr12:45367081-45367082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539030916 | chr12:45367104-45367105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373085350 | chr12:45367112-45367113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138574673 | chr12:45367133-45367134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73288980 | chr12:45367143-45367144 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs372327923 | chr12:45367144-45367145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544453166 | chr12:45367149-45367150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192104209 | chr12:45369233-45369234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530586078 | chr12:45369241-45369242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184196033 | chr12:45369272-45369273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188601386 | chr12:45369316-45369317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552371108 | chr12:45369353-45369354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376492162 | chr12:45369357-45369358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377651550 | chr12:45369376-45369377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571604883 | chr12:45369385-45369386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cancer | 20164919 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Gastric cancer | 18160780 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:45361800-45364200 | Enhancers | Dnd41 | blood |
2 | chr12:45362000-45364200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr12:45362000-45364200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr12:45362200-45364000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
5 | chr12:45366800-45367200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr12:45369200-45371000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr12:45369800-45370600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr12:45370600-45371800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr12:45371800-45372000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr12:45372000-45372400 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr12:45372400-45372800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr12:45386000-45387800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr12:45386200-45387000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr12:45393000-45412600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr12:45393200-45394600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr12:45394400-45394600 | ZNF genes & repeats | Cortex derived primary cultured neurospheres | brain |
17 | chr12:45394600-45406000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
18 | chr12:45398000-45398400 | Enhancers | HUES6 Cell Line | embryonic stem cell |